With Evidence of Progressive Disease on or Within 6 Months

DrugDrug NameDrug Description
DB05773Trastuzumab emtansineAn antineoplastic agent and antibody-drug conjugate used to treat HER2-overexpressing breast cancer.
DrugDrug NamePhaseStatusCount